Platelet aggregation-IN-3 - CAS 1029802-21-8

Platelet aggregation-IN-3 (Compound 5) acts as a ligand for H2 histamine receptors, α2 (A, C) -adrenergic receptors (α2-AR), and 5-HT2 (B, C) serotonin receptors. This compound can inhibit platelet aggregation induced by ADP and collagen, and it also modulates tumor cell-induced platelet aggregation (TCIPA) . Platelet aggregation-IN-3 is a promising candidate for anti-platelet therapy in cardiovascular disease and the prevention of cancer-associated thrombosis and tumor metastasis.

Histamine Receptor, 5-HT Receptor, Adrenergic Receptor

Neuroscience, GPCR/G Protein, Immunology/Inflammation

1029773

C13H18ClN3

251.755

Cl.N1=C(NC2=CC=C3C(=C2)CCCC3)NCC1

-20°C

Ice Packs

Small Compound